| Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma R Stupp, WP Mason, MJ Van Den Bent, M Weller, B Fisher, ... New England journal of medicine 352 (10), 987-996, 2005 | 22683 | 2005 |
| MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma ME Hegi, AC Diserens, T Gorlia, MF Hamou, N De Tribolet, M Weller, ... New England Journal of Medicine 352 (10), 997-1003, 2005 | 8494 | 2005 |
| Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the … R Stupp, ME Hegi, WP Mason, MJ Van Den Bent, MJB Taphoorn, ... The lancet oncology 10 (5), 459-466, 2009 | 8176 | 2009 |
| Response criteria for phase II studies of supratentorial malignant glioma. DR Macdonald, TL Cascino, SC Schold Jr, JG Cairncross Journal of clinical oncology 8 (7), 1277-1280, 1990 | 2772 | 1990 |
| Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas JG Cairncross, K Ueki, MC Zlatescu, DK Lisle, DM Finkelstein, ... JNCI: Journal of the National Cancer Institute 90 (19), 1473-1479, 1998 | 1906 | 1998 |
| Phase III trial of chemoradiotherapy for anaplastic oligodendroglioma: long-term results of RTOG 9402 G Cairncross, M Wang, E Shaw, R Jenkins, D Brachman, J Buckner, ... Journal of clinical oncology 31 (3), 337-343, 2013 | 1253 | 2013 |
| Gene expression-based classification of malignant gliomas correlates better with survival than histological classification CL Nutt, DR Mani, RA Betensky, P Tamayo, JG Cairncross, C Ladd, ... Cancer research 63 (7), 1602-1607, 2003 | 1170 | 2003 |
| European Organisation for Research and Treatment of Cancer Brain Tumour and Radiation Oncology Groups; National Cancer Institute of Canada Clinical Trials Group. Effects of … R Stupp, ME Hegi, WP Mason, MJ Van den Bent, MJ Taphoorn, ... Lancet Oncol 10 (5), 459-466, 2009 | 1111 | 2009 |
| Short-course radiation plus temozolomide in elderly patients with glioblastoma JR Perry, N Laperriere, CJ O’Callaghan, AA Brandes, J Menten, C Phillips, ... New England Journal of Medicine 376 (11), 1027-1037, 2017 | 1044 | 2017 |
| Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED] Report of the Quality Standards Subcommittee of the American Academy of … MJ Glantz, BF Cole, PA Forsyth, LD Recht, PY Wen, MC Chamberlain, ... Neurology 54 (10), 1886-1893, 2000 | 1029 | 2000 |
| Abbreviated course of radiation therapy in older patients with glioblastoma multiforme: a prospective randomized clinical trial W Roa, PMA Brasher, G Bauman, M Anthes, E Bruera, A Chan, B Fisher, ... Journal of clinical oncology 22 (9), 1583-1588, 2004 | 1025 | 2004 |
| Phase III trial of chemotherapy plus radiotherapy compared with radiotherapy alone for pure and mixed anaplastic oligodendroglioma: Intergroup Radiation Therapy Oncology Group … G Cairncross, B Berkey, E Shaw, R Jenkins, B Scheithauer, D Brachman, ... Journal of Clinical Oncology 24 (18), 2707-2714, 2006 | 858 | 2006 |
| Stem cell–related “self-renewal” signature and high epidermal growth factor receptor expression associated with resistance to concomitant chemoradiotherapy in glioblastoma A Murat, E Migliavacca, T Gorlia, WL Lambiv, T Shay, MF Hamou, ... Journal of clinical oncology 26 (18), 3015-3024, 2008 | 809 | 2008 |
| Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE. 3 T Gorlia, MJ van den Bent, ME Hegi, RO Mirimanoff, M Weller, ... The lancet oncology 9 (1), 29-38, 2008 | 642 | 2008 |
| Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review N Laperriere, L Zuraw, G Cairncross, ... Radiotherapy and Oncology 64 (3), 259-273, 2002 | 640 | 2002 |
| Radiotherapy and temozolomide for newly diagnosed glioblastoma: recursive partitioning analysis of the EORTC 26981/22981-NCIC CE3 phase III randomized trial RO Mirimanoff, T Gorlia, W Mason, MJ Van den Bent, RD Kortmann, ... Journal of clinical oncology 24 (16), 2563-2569, 2006 | 629 | 2006 |
| Molecular subtypes of anaplastic oligodendroglioma: implications for patient management at diagnosis Y Ino, RA Betensky, MC Zlatescu, H Sasaki, DR Macdonald, ... Clinical Cancer Research 7 (4), 839-845, 2001 | 557 | 2001 |
| Radation therapy for brain metastases JG Cairncross, JH Kim, JB Posner Annals of Neurology: Official Journal of the American Neurological …, 1980 | 554 | 1980 |
| Chemotherapy for anaplastic oligodendroglioma. National Cancer Institute of Canada Clinical Trials Group. G Cairncross, D Macdonald, S Ludwin, D Lee, T Cascino, J Buckner, ... Journal of Clinical Oncology 12 (10), 2013-2021, 1994 | 539 | 1994 |
| Changing paradigms—an update on the multidisciplinary management of malignant glioma R Stupp, ME Hegi, MJ Van Den Bent, WP Mason, M Weller, ... The oncologist 11 (2), 165-180, 2006 | 487 | 2006 |
